SE7602565L - Forfarande for framstellning av en ny kristallin form av ett cefalosporinsalt - Google Patents

Forfarande for framstellning av en ny kristallin form av ett cefalosporinsalt

Info

Publication number
SE7602565L
SE7602565L SE7602565A SE7602565A SE7602565L SE 7602565 L SE7602565 L SE 7602565L SE 7602565 A SE7602565 A SE 7602565A SE 7602565 A SE7602565 A SE 7602565A SE 7602565 L SE7602565 L SE 7602565L
Authority
SE
Sweden
Prior art keywords
crystalline form
cephalosporinsalt
procedure
preparation
new crystalline
Prior art date
Application number
SE7602565A
Other languages
Unknown language ( )
English (en)
Other versions
SE435290B (sv
Inventor
K S Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7602565L publication Critical patent/SE7602565L/sv
Publication of SE435290B publication Critical patent/SE435290B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE7602565A 1975-04-11 1976-02-26 Forfarande for framstellning av gamma-kristallin form av natrium-7-(d-alfa-formyloxi-alfa-fenylacetamido)-(2-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylat SE435290B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/567,324 US4006138A (en) 1975-04-11 1975-04-11 Crystalline form of sodium O-formylcefamandole

Publications (2)

Publication Number Publication Date
SE7602565L true SE7602565L (sv) 1976-10-12
SE435290B SE435290B (sv) 1984-09-17

Family

ID=24266692

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7602565A SE435290B (sv) 1975-04-11 1976-02-26 Forfarande for framstellning av gamma-kristallin form av natrium-7-(d-alfa-formyloxi-alfa-fenylacetamido)-(2-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylat

Country Status (31)

Country Link
US (1) US4006138A (sv)
JP (1) JPS51123812A (sv)
AR (1) AR210880A1 (sv)
AT (1) AT343806B (sv)
AU (1) AU500013B2 (sv)
BE (1) BE840179A (sv)
CA (1) CA1045114A (sv)
CH (1) CH621554A5 (sv)
CS (1) CS191970B2 (sv)
DD (1) DD125950A5 (sv)
DE (1) DE2614669C2 (sv)
DK (1) DK148022C (sv)
ES (1) ES446907A1 (sv)
FI (1) FI65069C (sv)
FR (1) FR2306698A1 (sv)
GB (1) GB1546898A (sv)
GR (1) GR59912B (sv)
HU (1) HU175592B (sv)
IL (1) IL49100A (sv)
LU (1) LU74740A1 (sv)
MX (1) MX3687E (sv)
NL (1) NL184258C (sv)
NO (1) NO151748C (sv)
OA (1) OA05290A (sv)
PL (1) PL104803B1 (sv)
PT (1) PT64917B (sv)
RO (1) RO68501A (sv)
SE (1) SE435290B (sv)
SU (1) SU668608A3 (sv)
YU (1) YU40643B (sv)
ZA (1) ZA761103B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7503274L (sv) * 1974-04-11 1975-10-13 Ciba Geigy Ag Cefalosporin
US4085277A (en) * 1975-01-30 1978-04-18 Fujisawa Pharmaceutical Co., Ltd. 7(2-Phenyl or thienyl-2-isonicotinoyloxyacetamido)-3-(1-methyl-1-H tetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid
FR2400519A1 (fr) * 1977-08-17 1979-03-16 Roussel Uclaf Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4946838A (en) * 1981-07-13 1990-08-07 E. R. Squibb & Sons, Inc. Crystalline anhydrous aztreonam
EP0432297A1 (en) * 1989-12-13 1991-06-19 Technologitschen Kombinat Sa Promischlena Mikrobiologia A method for the preparation of the sodium salt of O-formyl cefamandole
US5492903A (en) * 1990-06-19 1996-02-20 Takeda Chemical Industries Ltd. Crystalline esters of (+)-(5R, 6S)-6-[(R)-1-hydroxyethyl]-3-(3-pyridyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]he
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
WO2013057196A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of cefamandole nafate
CN104530086B (zh) * 2014-12-16 2015-12-09 天津大学 头孢孟多酯钠化合物的新晶型及其结晶制备方法
CN105037392A (zh) * 2015-08-13 2015-11-11 青岛蓝盛洋医药生物科技有限责任公司 一种杀菌药物头孢孟多酯钠化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887551A (en) * 1964-11-04 1975-06-03 Glaxo Lab Ltd Crystalline forms of cephaloridine
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
DE2614669C2 (de) 1984-09-27
PL104803B1 (pl) 1979-09-29
ZA761103B (en) 1977-10-26
FI65069B (fi) 1983-11-30
HU175592B (hu) 1980-09-28
NL184258B (nl) 1989-01-02
NL184258C (nl) 1989-06-01
NL7603660A (nl) 1976-10-13
FI760788A (sv) 1976-10-12
IL49100A (en) 1979-03-12
AU1143576A (en) 1977-09-01
BE840179A (fr) 1976-09-30
FR2306698B1 (sv) 1979-10-05
ATA258476A (de) 1977-10-15
LU74740A1 (sv) 1976-11-11
MX3687E (es) 1981-04-29
CH621554A5 (sv) 1981-02-13
OA05290A (fr) 1981-02-28
NO151748C (no) 1985-06-05
AU500013B2 (en) 1979-05-10
DK148022C (da) 1985-07-22
YU40643B (en) 1986-04-30
SU668608A3 (ru) 1979-06-15
SE435290B (sv) 1984-09-17
NO761017L (sv) 1976-10-12
CS191970B2 (en) 1979-07-31
JPS6110474B2 (sv) 1986-03-29
FI65069C (fi) 1984-03-12
AR210880A1 (es) 1977-09-30
PT64917A (en) 1976-04-01
YU79276A (en) 1982-10-31
DK148022B (da) 1985-02-04
AT343806B (de) 1978-06-26
DK150676A (da) 1976-10-12
GB1546898A (en) 1979-05-31
JPS51123812A (en) 1976-10-28
FR2306698A1 (fr) 1976-11-05
RO68501A (ro) 1981-04-30
DD125950A5 (sv) 1977-06-01
US4006138A (en) 1977-02-01
NO151748B (no) 1985-02-18
DE2614669A1 (de) 1976-10-21
IL49100A0 (en) 1976-04-30
GR59912B (en) 1978-03-20
PT64917B (en) 1977-08-24
CA1045114A (en) 1978-12-26
ES446907A1 (es) 1977-09-16

Similar Documents

Publication Publication Date Title
JPS5498790A (en) Manufacture of novel heterocyclic compound
NO161495C (no) Fremgangsmaate for fremstilling av (d-alfa-amino-(p-hydroksyfenyl)acetamido))-gruppeholdige cefalosporansyrederivater.
SE7710698L (sv) Forfarande for framstellning av pseudotrisackarider
SE7602565L (sv) Forfarande for framstellning av en ny kristallin form av ett cefalosporinsalt
SE416298B (sv) Forfarande for framstellning av nya bensimidazolinon derivat
ES8200695A1 (es) Procedimiento para la preparacion de cefalosporinas cromofo-ras
SE431548B (sv) Forfarande for framstellning av nya cefalosporinderivat
SE417408B (sv) Borrenhet for framstellning av ett underskuret borrhal
AR203895A1 (es) Procedimiento para preparar una composicion antibiotica seca de 7-(d-2-formiloxi-2-fenilacetamido)-3-(1-metil-1h-tetrazol-5-il-tiometil)-3-cefem- -carboxilato de sodio
BE884385A (fr) Production d'une cephalosporine par fermentation
SE7614401L (sv) Forfarande for framstellning av natriumcefamandolanhydrat i kristalliserad form
ES473787A1 (es) Un procedimiento para la preparacion de derivados de oxadia-zolopirimidina.
SE7513640L (sv) Forfarande for framstellning av 6-metyl-8-(substituerade) metylerogoliner
FR2355848A1 (fr) 7-(a-(2,3-dihydro-2-oxobenzimidazol-1-yl-carbonylamino) arylacetamido) cephalosporines
SE7508793L (sv) Antibiotiska derivat av xk-62-2 samt forfarande for framstellning derav
FI54495C (fi) Foerfarande foer framstaellning av ett gentemot gram-positiva bakterier aktivt polypeptid-antibiotikum benaemnd gardimycin
SE427184B (sv) Forfarande for framstellning av 7-aminocefalosporansyraderivat
SE430162B (sv) Nytt forfarande for framstellning av cefalosporinderivat
SE421127B (sv) Ett nytt forfarande for framstellning av cefalosporin- och penicillinderivat
ES449688A1 (es) Procedimiento para la preparacion de un acido 7-(alfa-amino-w-(3, 4-metilenodioxifenil) acilamido) cefalosporanico.
DK296676A (da) Fremgangsmade til fremstilling af 7-(alfa-amino-omega-(2,3-methylen-dioxyphenyl)acylamido)cephalosporansyrederivater
SU639455A3 (ru) Способ получени производных цефалоспорина
AU499249B2 (en) Production of 2-imino 3-(2-chloro-2-phenylethyl) thiazolidine & tetramisole therefrom
SE434952B (sv) Forfarande for framstellning av nya cefalosporinderivat
JPS5253890A (en) Production of cephalosporin type compound

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7602565-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7602565-9

Format of ref document f/p: F